Sunshine Biopharma Inc. Gain (Loss) Related to Litigation Settlement
Sunshine Biopharma Inc. (SBFM) reported Gain (Loss) Related to Litigation Settlement of $0 for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-15.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2017-11-15
- Sunshine Biopharma Inc. gain (loss) related to litigation settlement for the quarter ending 2017-09-30 was $0.00.
- Sunshine Biopharma Inc. gain (loss) related to litigation settlement for the quarter ending 2017-06-30 was $0.00.
- Sunshine Biopharma Inc. gain (loss) related to litigation settlement for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. gain (loss) related to litigation settlement for the quarter ending 2016-09-30 was $0.00.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month |
|---|---|---|---|
| 2017-09-30 | $0.00 10-Q · filed 2017-11-15 | $0.00 derived: sum of 2 quarters · filed 2017-11-15 | $0.00 10-Q · filed 2017-11-15 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-12 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-15 | $0.00 derived: sum of 2 quarters · filed 2017-11-15 | $25.00K 10-Q · filed 2017-11-15 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-11 | $25.00K 10-Q · filed 2017-08-11 | |
| 2016-03-31 | $25.00K 10-Q · filed 2017-05-12 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-16 | $0.00 10-Q · filed 2016-08-16 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |